PACIULLO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 1.165
NA - Nord America 666
EU - Europa 481
SA - Sud America 317
AF - Africa 33
OC - Oceania 10
Totale 2.672
Nazione #
US - Stati Uniti d'America 609
SG - Singapore 562
BR - Brasile 274
CN - Cina 231
HK - Hong Kong 190
IT - Italia 173
DE - Germania 85
VN - Vietnam 54
GB - Regno Unito 44
CA - Canada 34
IN - India 34
AT - Austria 31
NL - Olanda 29
FR - Francia 18
PL - Polonia 18
AR - Argentina 17
BD - Bangladesh 16
IE - Irlanda 15
MX - Messico 13
RU - Federazione Russa 13
ID - Indonesia 11
SE - Svezia 11
AU - Australia 10
FI - Finlandia 10
ZA - Sudafrica 10
ES - Italia 9
IQ - Iraq 9
TR - Turchia 9
LT - Lituania 8
JP - Giappone 6
PH - Filippine 6
CO - Colombia 5
DO - Repubblica Dominicana 5
EC - Ecuador 5
PE - Perù 5
UZ - Uzbekistan 5
BE - Belgio 4
BW - Botswana 4
LA - Repubblica Popolare Democratica del Laos 4
PK - Pakistan 4
VE - Venezuela 4
BG - Bulgaria 3
CL - Cile 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
NG - Nigeria 3
PY - Paraguay 3
UA - Ucraina 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
MY - Malesia 2
RO - Romania 2
SA - Arabia Saudita 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
EG - Egitto 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
KR - Corea 1
MA - Marocco 1
MN - Mongolia 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 2.672
Città #
Singapore 335
Hong Kong 190
Dallas 111
Ashburn 88
Hefei 76
Shanghai 58
Milan 48
New York 41
Los Angeles 33
São Paulo 30
Boardman 29
Nuremberg 26
Munich 25
Ho Chi Minh City 17
Beijing 15
Denver 15
Dublin 15
Montreal 15
Vienna 15
Santa Clara 14
Warsaw 14
Brooklyn 13
Hanoi 13
London 12
Frankfurt am Main 11
Orem 11
Amsterdam 10
Bengaluru 10
Boston 10
Falkenstein 10
Atlanta 9
Manchester 9
Rio de Janeiro 9
Stockholm 9
Johannesburg 8
Phoenix 8
Rome 8
Helsinki 7
Poplar 7
Belo Horizonte 6
Bologna 6
Mexico City 6
Mumbai 6
San Francisco 6
Sydney 6
Tokyo 6
Toronto 6
Turin 6
Ankara 5
Calgary 5
Chennai 5
Chicago 5
Guangzhou 5
Houston 5
Tashkent 5
Fortaleza 4
Gaborone 4
Genoa 4
Guarulhos 4
Miami 4
Natal 4
Santo Domingo 4
Seattle 4
St Louis 4
Vientiane 4
Addis Ababa 3
Amman 3
Bari 3
Bogotá 3
Brussels 3
Catania 3
Charlotte 3
City of London 3
Concord 3
Curitiba 3
Duque de Caxias 3
Jundiaí 3
Koronadal 3
Lima 3
Maracanaú 3
Maricá 3
Moscow 3
Nairobi 3
Sant Antoni de Vilamajor 3
Santo André 3
Saquarema 3
São Carlos 3
Tianjin 3
Assago 2
Asunción 2
Athens 2
Augusta 2
Baghdad 2
Baku 2
Bauru 2
Campos dos Goytacazes 2
Castellammare di Stabia 2
Changsha 2
Contagem 2
Cotia 2
Totale 1.606
Nome #
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 90
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study 79
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 77
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 69
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 62
Deficiency of natural anticoagulants: how should we manage cardiovascular prevention? 61
Measurement of arterial stiffness in antiphospholipid syndrome: a step forward in cardiovascular risk stratification? 54
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 53
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 53
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 52
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 51
Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people 51
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 51
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) 51
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 50
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 49
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 49
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 46
Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A 45
Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016 44
Antipsychotic prescription and mortality in hospitalized older persons 44
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 43
Effect of statins on measures of coagulation: potential role of low-density lipoprotein receptors 42
Antibiotic use and associated factors in a large sample of hospitalised older people 42
Gender-differences in disease distribution and outcome in hospitalized elderly : Data from the REPOSI study 42
Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis 41
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 39
Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival 39
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 37
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 36
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 36
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 35
The response of the emergency-urgency system in Umbria during the COVID-19 pandemic 35
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 35
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 35
Heart failure and chronic kidney disease in a registry of internal medicine wards 34
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 34
Antithrombotic treatment of asymptomatic carotid atherosclerosis: a medical dilemma 33
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 33
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 33
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 32
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 32
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 31
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 30
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 30
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 30
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 29
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 29
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 29
Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes 29
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy 29
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry 28
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 28
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 27
Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia 27
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 26
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness 26
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 25
PCSK9 at the crossroad of cholesterol metabolism and immune function during infections 25
Strategies for prevention of SARS-CoV-2 infection in a rural Emergency Department 24
Increased plasma PCSK-9 is associated with restenosis in patients undergoing carotid endarterectomy 23
Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study 23
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 23
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 23
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey 23
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 23
Epidemiology of emergency calls for time-dependent acute illnesses during COVID-19 outbreak in Umbria region (Italy) 22
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study 22
High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes 19
Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels 19
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 19
Eltrombopag to allow chemotherapy in a patient withMYH9-related inherited thrombocytopenia and pancreatic cancer 18
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 17
Pleiotropic effects of PCSK9-inhibition on hemostasis: Anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression 16
Olanzapine-associated hypothermia: a case report of a rare event 15
Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity 15
Totale 2.771
Categoria #
all - tutte 13.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 0 0 19 9
2024/20251.028 43 2 6 80 52 110 252 70 99 107 89 118
2025/20261.715 299 346 193 433 292 152 0 0 0 0 0 0
Totale 2.771